DE69616791D1 - Zusammensetzungen und verfahren zum stabilisieren von polymeren - Google Patents

Zusammensetzungen und verfahren zum stabilisieren von polymeren

Info

Publication number
DE69616791D1
DE69616791D1 DE69616791T DE69616791T DE69616791D1 DE 69616791 D1 DE69616791 D1 DE 69616791D1 DE 69616791 T DE69616791 T DE 69616791T DE 69616791 T DE69616791 T DE 69616791T DE 69616791 D1 DE69616791 D1 DE 69616791D1
Authority
DE
Germany
Prior art keywords
compositions
stabilizing polymers
poly
strong
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69616791T
Other languages
English (en)
Other versions
DE69616791T2 (de
Inventor
Fu-Pao Tsao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE69616791D1 publication Critical patent/DE69616791D1/de
Application granted granted Critical
Publication of DE69616791T2 publication Critical patent/DE69616791T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/49—Phosphorus-containing compounds
    • C08K5/51—Phosphorus bound to oxygen
    • C08K5/53—Phosphorus bound to oxygen bound to oxygen and to carbon only
    • C08K5/5317—Phosphonic compounds, e.g. R—P(:O)(OR')2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Materials For Medical Uses (AREA)
DE69616791T 1995-06-22 1996-06-12 Zusammensetzungen und verfahren zum stabilisieren von polymeren Expired - Lifetime DE69616791T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/493,761 US5683993A (en) 1995-06-22 1995-06-22 Compositions and methods for stabilizing polymers
PCT/EP1996/002539 WO1997000669A1 (en) 1995-06-22 1996-06-12 Compositions and methods for stabilizing polymers

Publications (2)

Publication Number Publication Date
DE69616791D1 true DE69616791D1 (de) 2001-12-13
DE69616791T2 DE69616791T2 (de) 2002-05-29

Family

ID=23961593

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69616791T Expired - Lifetime DE69616791T2 (de) 1995-06-22 1996-06-12 Zusammensetzungen und verfahren zum stabilisieren von polymeren

Country Status (13)

Country Link
US (2) US5683993A (de)
EP (1) EP0833609B1 (de)
JP (3) JP4260881B2 (de)
AT (1) ATE208189T1 (de)
AU (1) AU715686B2 (de)
CA (1) CA2222646C (de)
CY (1) CY2323B1 (de)
DE (1) DE69616791T2 (de)
DK (1) DK0833609T3 (de)
ES (1) ES2167581T3 (de)
PT (1) PT833609E (de)
TW (1) TW358109B (de)
WO (1) WO1997000669A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010012188A (ko) * 1997-05-14 2001-02-15 요시다 쇼지 재분산성이 양호한 수성 현탁액제
EP0893121B1 (de) * 1997-06-27 2002-03-13 Akzo Nobel N.V. Oral anzuwendende flüssige Arzneilösung
DE19744113A1 (de) * 1997-10-06 1999-04-15 Mann Gerhard Chem Pharm Fab Dexamethason-Gel
EP0938896A1 (de) * 1998-01-15 1999-09-01 Novartis AG In Autoklaven behandelbare pharmazeutische Zusammensetzungen mit Komplexbildner
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US6627660B1 (en) * 1999-11-16 2003-09-30 New River Pharmaceuticals Inc. Stabilized thyroxine compounds
NZ525664A (en) 2000-11-17 2008-08-29 Kirin Holdings Kk Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
AU2002360939A1 (en) * 2001-11-21 2003-06-10 Novartis Ag Composition for stabilizing hyaluronic acid
US20040115160A1 (en) * 2002-12-13 2004-06-17 Salamone Joseph C. Quaternary ammonium esters for disinfection and preservation
US20050084468A1 (en) * 2003-10-17 2005-04-21 Colgate-Palmolive Company Antimicrobial cleaning composition
WO2007109523A2 (en) 2006-03-17 2007-09-27 Johnson & Johnson Vision Care, Inc. Stabilized ophthalmic compositions comprising oxidatively unstable components
JP5160757B2 (ja) * 2006-09-01 2013-03-13 ホーユー株式会社 毛髪脱染剤組成物
TWI394564B (zh) * 2006-09-21 2013-05-01 Alcon Res Ltd 自行保存型水性藥學組成物
US20100021561A1 (en) * 2006-09-21 2010-01-28 Chowhan Masood A Self-preserved aqueous pharmaceutical compositions
JP5394927B2 (ja) * 2006-09-28 2014-01-22 アルコン リサーチ， リミテッド 自己保存性水性医薬品組成物
JP5216596B2 (ja) * 2006-10-26 2013-06-19 千寿製薬株式会社 眼科用水性液剤
AU2008233256B2 (en) 2007-03-28 2013-06-27 The Curators Of The University Of Missouri Transgenic animal models of disease
US8759321B2 (en) 2007-06-13 2014-06-24 Bausch & Lomb Incorporated Ophthalmic composition with hyaluronic acid and polymeric biguanide
US8119112B2 (en) 2008-01-31 2012-02-21 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid
KR101541303B1 (ko) * 2008-03-17 2015-08-03 알콘 리서치, 리미티드 보레이트-폴리올 복합체를 함유하는 수성 약학적 조성물
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
WO2010135731A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
TWI489997B (zh) * 2009-06-19 2015-07-01 Alcon Res Ltd 含有硼酸－多元醇錯合物之水性藥學組成物
HUE039793T2 (hu) 2011-05-16 2019-02-28 Univ Missouri Sertés reproduktív és légzési szindróma vírus rezisztens állatok
WO2013067328A1 (en) 2011-11-03 2013-05-10 University Of Iowa Research Foundation Transgenic pig models of cystic fibrosis
US20130177599A1 (en) * 2012-01-06 2013-07-11 Insite Vision Incorporated Methods and kits for extending contact lens use
KR101400791B1 (ko) 2012-10-04 2014-05-29 주식회사대성미생물연구소 동물용 복합 기능성 항생제 조성물
WO2016187426A1 (en) 2015-05-19 2016-11-24 Amorphex Therapeutics Llc A device that delivers a sustained low-dose of a myopia-suppressing drug
US10413505B1 (en) 2017-02-07 2019-09-17 Genus Lifesciences Inc. Pharmaceutical compositions and methods of using the same
US10149843B1 (en) 2017-02-07 2018-12-11 Gneus Lifescineces Inc. Pharmaceutical compositions and methods of using the same
US10231961B1 (en) 2017-02-07 2019-03-19 Genus Lifesciences Inc. Pharmaceutical compositions and methods of using the same
CN109387622A (zh) * 2018-03-02 2019-02-26 国家纳米科学中心 一种高分子材料表面修饰方法及其应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322883A1 (de) * 1973-05-07 1974-11-28 Roehm Gmbh Wasserloesliche polymerisate
DE2743764C2 (de) * 1977-09-29 1982-07-22 Hoechst Ag, 6000 Frankfurt Wäßrige Kunststoffdispersion auf Basis von Vinylpolymeren
DE2810348A1 (de) * 1978-03-10 1979-09-20 Hoechst Ag Waessrige kunststoffdispersion auf basis von vinylpolymeren
US4303568A (en) * 1979-12-10 1981-12-01 Betz Laboratories, Inc. Corrosion inhibition treatments and method
US4474916A (en) * 1982-07-27 1984-10-02 Basf Aktiengesellschaft Concentrated aqueous solutions of mixtures of organic complexing agents and dispersing agents based on polymeric aliphatic carboxylic acids
ATE151286T1 (de) * 1983-11-14 1997-04-15 Columbia Lab Inc Bioadhäsive mittel
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
US4540738A (en) * 1984-12-07 1985-09-10 The Kendall Company Acrylic adhesive composition comprising an alpha amino phosphonic acid or salt having improved stability
US4889689A (en) * 1986-10-14 1989-12-26 Ciba-Geigy Corporation Method of disinfecting a soft contact lens with a diethylene triamine penta(methylenephosphonic acid) stabilized hydrogen peroxide solution
US4900469A (en) * 1986-10-21 1990-02-13 The Clorox Company Thickened peracid precursor compositions
US4812173A (en) * 1987-05-01 1989-03-14 Ciba-Geigy Corporation Stabilized hydrogen peroxide contact lens disinfecting solution
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
DE3805663A1 (de) * 1988-02-24 1989-09-07 Henkel Kgaa Oxaalkanpolyphosphonsaeuren, ihre verwendung als thresholder sowie diese verbindungen enthaltende, komplexierend wirkende zusammensetzungen
EP0706802B1 (de) * 1988-08-04 2004-03-24 Novartis AG Verfahren zur Konservierung ophthalmischer Lösungen und Zusammensetzungen dafür
US4960799A (en) * 1988-09-13 1990-10-02 Ciba-Geigy Corporation Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
US5034556A (en) * 1989-04-03 1991-07-23 Ppg Industries, Inc. Reaction products of alpha-aminomethylene phosphonic acids and epoxy compounds and their use in coating compositions
US5300296A (en) * 1989-11-06 1994-04-05 Frank J. Holly Antimicrobial agent for opthalmic formulations
JP3008131B2 (ja) * 1990-11-14 2000-02-14 ロレアル グリセリンから誘導される非イオン両親媒性化合物、その調製方法、相応する中間体化合物及び前記化合物を含有する組成物
JP2875887B2 (ja) * 1990-12-27 1999-03-31 アラーガン インコーポレイテッド コンタクトレンズの消毒法および消毒用組成物
JP3107873B2 (ja) * 1991-09-26 2000-11-13 ユニ・チャーム株式会社 高吸水性ポリマーの経時着色防止方法および経時着色防止剤
EP0544377B1 (de) * 1991-11-26 1996-05-22 ENIRICERCHE S.p.A. Wässrige gelierbare Zusammensetzung enthaltend ein Anti-Syneresis-Agens
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
SE500660C2 (sv) * 1992-12-03 1994-08-01 Mo Och Domsjoe Ab Förfarande för framställning av grönlut vid kemikalieåtervinning i sulfat- och sulfitmassafabriker
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
EP0638685B1 (de) * 1993-08-10 1998-12-23 Ciba SC Holding AG Mercerisiernetzmittel
FR2726762B1 (fr) * 1994-11-10 1997-01-17 Oreal Composition cosmetique ou dermatologique sous forme d'une dispersion d'une phase huileuse dans une phase aqueuse stabilisee a l'aide de particules de gel cubique et son procede d'obtention
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds

Also Published As

Publication number Publication date
EP0833609B1 (de) 2001-11-07
PT833609E (pt) 2002-04-29
AU715686B2 (en) 2000-02-10
TW358109B (en) 1999-05-11
EP0833609A1 (de) 1998-04-08
CA2222646C (en) 2009-12-08
WO1997000669A1 (en) 1997-01-09
DK0833609T3 (da) 2002-02-18
JP2012153710A (ja) 2012-08-16
US5683993A (en) 1997-11-04
DE69616791T2 (de) 2002-05-29
US5858996A (en) 1999-01-12
ATE208189T1 (de) 2001-11-15
JPH11510480A (ja) 1999-09-14
JP2008248246A (ja) 2008-10-16
AU6355196A (en) 1997-01-22
JP4260881B2 (ja) 2009-04-30
ES2167581T3 (es) 2002-05-16
CA2222646A1 (en) 1997-01-09
CY2323B1 (en) 2003-11-14

Similar Documents

Publication Publication Date Title
DE69616791D1 (de) Zusammensetzungen und verfahren zum stabilisieren von polymeren
ATE547122T1 (de) Zusammensetzung zur stabilisierung von hyaluronsäure
DE59610087D1 (de) Verfahren zur Modifizierung von Dispersionspulver-Zusammensetzungen
ATE244745T1 (de) Elektrochromes medium mit konzentration verbesserter stabilität, verfahren zu seiner herstellung und seiner verwendung
DE60110106D1 (de) Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
ATE388758T1 (de) Verfahren zum auflösen lipophiler verbindungen, und kosmetische zusammensetzung.
DE60012981D1 (de) Verfahren zur herstellung von polymeren durch eine kontrollierte radikalischpolymerisation mit xanthaten
ATE295254T1 (de) Verfahren zum extrudieren von mikrozellenpolymeren
ATE335011T1 (de) Verfahren zur vernetzung von hyaluronsäure mit polymeren
ATE210950T1 (de) Selbsthärtende calciumphosphatzemente und verfahren zu deren herstellung und verwendung
DE69426419D1 (de) Silylierte Polyamin-Polymere als Schmiermittel mit und ohne andere Komponenten, mit den Polymeren behandelte Substrate und Verfahren zur Behandlung der Substrate
DE60324435D1 (de) Verfahren zur herstellung von wasserlöslichen polymerderivaten mit terminalen carboxylgruppen
BR0015470A (pt) Composição de poliéster capaz de ser tingida com ácido, mistura, composição de poliéster tingida com ácido, processo para a prepação de uma composição de poliéster capaz de ser tingida com ácido e composto
DE69930968D1 (de) Verfahren zur herstellung von polyarylensulfiden
DE50000930D1 (de) Verfahren zur sofortbeendigung von radikalischen polymerisationen
ATE361343T1 (de) Verfahren zur herstellung von schmelzverarbeitbare zusammensetzungen, zusammensetzungen und artikeln
DK0663208T3 (da) Kombinationer af polymerer til anvendelse i kunstige tårepræparater
DE59912996D1 (de) Verfahren zur stabilisierung von ethylenisch ungesättigten verbindungen gegen unerwunschte radikalische polymerisation
DE60238972D1 (de) Verfahren zur entfernung von polymerfilmen bei der herstellung von acrylatcopolymer enthaltenden wässrigen zusammensetzungen
DE60316970D1 (de) Arzneistoffzufuhrverfahren unter verwendung von sulfatierten chitinösen polymeren
HUP0402190A2 (hu) Halogéntartalmú polimerek előstabilizálása
ATE305484T1 (de) Flüssiginitiator zur beschleunigten durchführung der anionischen lactampolymerisation, verfahren zu dessen herstellung und verwendung
ATE155789T1 (de) Verfahren zur herstellung von aminomethanphosphonsäure
ATE282616T1 (de) Verfahren zur herstellung von wasserfreien mirtazapin-kristallen.
DE50209356D1 (de) Verfahren zur durchführung von polymerisationsreaktionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN